Blood eosinophil count (more than 260 per liter) and fractional exhaled nitric oxide (FeNO) values above 19.5 parts per billion strongly indicate whether individuals with severe allergic asthma are responsive to anti-IgE antibodies that will lower exacerbation incidence in asthma patients [22,93,94]. The gene discussed is IGHE; the disease is asthma.